• Target

    Open

  • Type

    Equity

  • Close Date

    Open

  • Status

    Open

RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to sell shares; the loss of the value of investment; and dilution of shareholding. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme. Please read FULL risk warning.

Ancon

Revolutionary molecular detection technology, which presents a unique solution to many industries including security, air pollution and healthcare.

Logo

Investment closes only once the total pledged amount passes the minimum of £500,000

Total Pledged: £457,000
Max

£1,000,000

This Pledge is not a commitment. You will be asked to confirm in the next section.

Track
Contact
Companies
House
Twitter

Overview

ANCON has developed and patented a disruptive technology which offers the company exciting market opportunities with the next generation of products to detect explosives, chemical weapons, narcotics and pollution in the air. The technology also has the future development potential to offer a new, non-invasive, screening and diagnostic technology, for detecting early stages of disease within the Healthcare and Veterinary sectors.

Deal Manager avatar

Deal Manager
Nick Taylor

  • Sector: Technology / IT / Software
  • Region: UK: South-East
  • Stage: Established - existing revenue, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £5,500,000
This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Deal documents

This section is currently locked.
Please Sign Up or Log In to unlock.